Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when TherapeuticsMD, Inc. publishes a filing, an earnings call transcript or a press release.

Get TXMD alerts

About Marlan D. Walker

Marlan D. Walker is recorded as General Counsel and CEO at TherapeuticsMD, Inc. (TXMD). The newest filing on record that lists Marlan D. Walker as CEO at TherapeuticsMD, Inc. (TXMD) is dated November 3, 2025. The newest filing on record that lists Marlan D. Walker as General Counsel at TherapeuticsMD, Inc. (TXMD) is dated April 14, 2021. The proxy statement of TherapeuticsMD, Inc. reports total compensation of $759,174 for Marlan D. Walker in fiscal 2024, including a base salary of $500,000. Disclosed compensation is on record for 4 fiscal years. TherapeuticsMD, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at TherapeuticsMD, Inc. includes Brian Bernick (CEO), Mark Glickman (CEO), Robert Finizio (CEO and Board Member) and 7 others.

Affiliation history

Company network

Current role

Drug Manufacturers - Specialty & Generic · Healthcare

General Counsel, CEO

Leadership on record at TherapeuticsMD, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2024 TherapeuticsMD, Inc. (TXMD) $500,000 $759,174
2023 TherapeuticsMD, Inc. (TXMD) $476,462 $1,019,817
2022 TherapeuticsMD, Inc. (TXMD) $424,500 $1,573,380
2021 TherapeuticsMD, Inc. (TXMD) $415,000 $1,597,193

Recent activity

No call appearances or filed executive changes recorded yet.